Therapeutic trials in muscular dystrophy. I. Gold in murine dystrophy

A. Enomoto, W. G. Bradley

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


A trial of sodium aurothiomalate as an antiproteinase drug in the treatment of murine muscular dystrophy is reported. A blind controlled comparison of high (25 μg/10 g body weight) and low dose gold (5 μg/10 g body weight) with saline-injected control animals was made, all injections being given 3 times weekly. The body weights and functional ability of the mice were assessed at weekly intervals. No significant difference between the groups was observed. A trial of very high dose chrysotherapy (500 μg of gold/10 g body weight) also showed no therapeutic benefit.

Original languageEnglish (US)
Pages (from-to)404-407
Number of pages4
JournalJournal of Neurology Neurosurgery and Psychiatry
Issue number5
StatePublished - 1978
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology
  • Psychiatry and Mental health


Dive into the research topics of 'Therapeutic trials in muscular dystrophy. I. Gold in murine dystrophy'. Together they form a unique fingerprint.

Cite this